Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, April 2, 2024

Stroke in Pregnancy: An Update

 How will your doctor work with a functioning stroke doctor to guarantee you won't have a stroke via pregnancy? This is non-negotiable!

Stroke in Pregnancy: An Update

, ,
https://doi.org/10.1016/j.ncl.2018.09.010Get rights and content

Section snippets

Key points

  • Pregnancy and puerperium confer a substantially increased risk of ischemic and hemorrhagic stroke in women, the rates of which have increased approximately 50% to 80% over the past 20 years.

  • The period of highest risk of stroke is the peripartum/postpartum phase, coinciding with the highest risk for hypertensive disorders of pregnancy and peak risk of gestational hypercoagulability.

  • Hemorrhagic stroke is the most common type of obstetric stroke, most commonly associated with hypertensive

Incidence, Prevalence, and Temporal Trends

Pregnancy and puerperium confer an increased risk for ischemic as well as hemorrhagic stroke, with incidence rates being 3-fold higher as compared with nonpregnant women. A recent meta-analysis of the epidemiologic characteristics and risk factors for stroke in pregnancy found that the mean age ranged from 22 to 33 years, and the crude incidence rate was 30/100,000 (95% confidence interval [CI], 18.8–49.4/100,000).1 The rate of ischemic and hemorrhagic stroke was 12.2/100,000 pregnancies,

Patient Characteristics

A study of the Nationwide Inpatient Sample showed that the absolute risk of stroke increased with age: compared with patients younger than 20 years, those aged 35 to 39 years had an odds ratio (OR) for stroke of 2.0 (95% CI 1.4–2.7, P<.01) and those older than or equal to 40 years had OR of 3.1 (95% CI 2–4.6).5 One study found that younger women, but not older women, had an increased stroke risk during pregnancy and the postpartum state.6 Pregnancy at older age may, however, have negative

Hemodynamic Changes

During pregnancy, there is a high metabolic demand. To account for this, cardiovascular changes occur to allow the maternal circulation to meet new physiologic requirements. One of the initial changes is an increase in the plasmatic volume beginning early in the first trimester, secondary to an increase in renin activity as stimulated by estrogen and other circulating hormones. There is also development of mild hemodilutional anemia, and substantial increases in heart rate and cardiac output,

Hypertensive Disorders of Pregnancy

HDP are a group of conditions occurring in pregnancy and puerperium with a common background of hypertension, defined as BP greater than or equal to 140/90 mm Hg. Included in this group are gestational hypertension, preeclampsia, severe preeclampsia (eclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome), and chronic hypertension with superimposed preeclampsia. HDP are of clinical relevance, given their prevalence and strong risk of cardiovascular disease and stroke during

Acute Ischemic Stroke Management

For nonpregnant patients with acute ischemic stroke, early thrombolytic therapy and endovascular clot retrieval are the recommended hyperacute therapies to improve long-term clinical outcomes. However, these therapies have not been studied in randomized trials involving pregnant women. Further, this therapy is often withheld in many women, given concerns for life-threatening maternal and placental hemorrhages, including risk of fetal demise. The most widespread used thrombolytic, tissue

Morbidity and Mortality

Stroke morbidity is determined by the type of stroke, its severity, and therapies received for early management and secondary prevention. Mortality rates for stroke in pregnancy are reported at 2.7% to 20.4% and have not significantly changed over the past decades, despite advances in stroke treatment.1

Risk of Recurrent Stroke

For women of child-bearing age who have a stroke or VST, the risk of a recurrent stroke during pregnancy is not substantially high. A study of 441 women with a first ever stroke followed for

First page preview

First page preview
Click to open first page preview

No comments:

Post a Comment